Ayaka Yamamoto

1.8k total citations · 1 hit paper
37 papers, 1.4k citations indexed

About

Ayaka Yamamoto is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Ayaka Yamamoto has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Pathology and Forensic Medicine and 7 papers in Physiology. Recurrent topics in Ayaka Yamamoto's work include Peroxisome Proliferator-Activated Receptors (4 papers), Biomedical Research and Pathophysiology (3 papers) and Tea Polyphenols and Effects (3 papers). Ayaka Yamamoto is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (4 papers), Biomedical Research and Pathophysiology (3 papers) and Tea Polyphenols and Effects (3 papers). Ayaka Yamamoto collaborates with scholars based in Japan, United States and Australia. Ayaka Yamamoto's co-authors include Ichizo Nishino, Ikuya Nonaka, Michio Hirano, Salvatore DiMauro, Shin J. Oh, Takeshi Yamada, Jin Fu, Sadatomo Shimojo, Kurenai Tanji and Edward Byrne and has published in prestigious journals such as Nature, Applied and Environmental Microbiology and Annals of Neurology.

In The Last Decade

Ayaka Yamamoto

37 papers receiving 1.3k citations

Hit Papers

Primary LAMP-2 deficiency causes X-linked vacuolar cardio... 2000 2026 2008 2017 2000 200 400 600

Peers

Ayaka Yamamoto
Se‐Jin Jeong South Korea
Trent D. Evans United States
Kathleen C. Lundberg United States
Lei Yin United States
Yolanda Olmos United Kingdom
Judith Y. Altarejos United States
Bounleut Phanavanh United States
Se‐Jin Jeong South Korea
Ayaka Yamamoto
Citations per year, relative to Ayaka Yamamoto Ayaka Yamamoto (= 1×) peers Se‐Jin Jeong

Countries citing papers authored by Ayaka Yamamoto

Since Specialization
Citations

This map shows the geographic impact of Ayaka Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayaka Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayaka Yamamoto more than expected).

Fields of papers citing papers by Ayaka Yamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayaka Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayaka Yamamoto. The network helps show where Ayaka Yamamoto may publish in the future.

Co-authorship network of co-authors of Ayaka Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ayaka Yamamoto. A scholar is included among the top collaborators of Ayaka Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayaka Yamamoto. Ayaka Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Ayaka, et al.. (2024). Increased ROS levels in mitochondrial outer membrane protein Mul1‐deficient oocytes result in abnormal preimplantation embryogenesis. FEBS Letters. 598(14). 1740–1752. 1 indexed citations
2.
Yamamoto, Ayaka, et al.. (2023). Intermolecular 1,3‐Dipolar Cycloaddition Reaction of N‐Carbamoyl Nitrones Generated by N‐Selective Carbamoylation of Oximes with Isocyanates. Chemistry - A European Journal. 30(9). e202303790–e202303790. 2 indexed citations
3.
Yamamoto, Ayaka, Jiro Ogura, Norikazu Watanabe, et al.. (2022). The safety of pranlukast and montelukast during the first trimester of pregnancy: A prospective, two‐centered cohort study in Japan. Congenital Anomalies. 62(4). 161–168. 11 indexed citations
4.
Yamamoto, Ayaka, Yoshitsugu Chigusa, Masakazu Fujimoto, et al.. (2021). Sebaceous carcinoma of the vulva treated with sentinel lymph node biopsy: a case report and literature review. International Cancer Conference Journal. 10(3). 239–243. 4 indexed citations
5.
Yamamoto, Ayaka, Takehiro Azuma, Seiichiro Kamimura, Yoshiaki Kitamura, & Noriaki Takeda. (2020). A Case of Rosai-Dorfman Disease with Multiple Extranodal Lesion. Practica Oto-Rhino-Laryngologica. 113(5). 323–329. 1 indexed citations
6.
Miyamoto, Keisuke, Ayaka Yamamoto, Yumi Moriyama, et al.. (2019). Synergistic Effects of Olaparib and DNA-damaging Agents in Oesophageal Squamous Cell Carcinoma Cell Lines. Anticancer Research. 39(4). 1813–1820. 14 indexed citations
7.
Toda, Kazuya, Shogo Senga, Koichiro Kawaguchi, et al.. (2019). Isolation and characterization of a novel oligomeric proanthocyanidin with significant anti-cancer activities from grape stems (Vitis vinifera). Scientific Reports. 9(1). 12046–12046. 14 indexed citations
8.
Senga, Shogo, Koichiro Kawaguchi, Ayaka Yamamoto, et al.. (2019). Identification and characterization of oligomeric proanthocyanidins with significant anti-cancer activity in adzuki beans (Vigna angularis). Heliyon. 5(10). e02610–e02610. 24 indexed citations
9.
Yamagata, Kazutsune, Tomomi Nakao, Linda J. Sandell, et al.. (2017). Mllt10 knockout mouse model reveals critical role of Af10-dependent H3K79 methylation in midfacial development. Scientific Reports. 7(1). 11922–11922. 11 indexed citations
11.
Inoue, Maki, Ayaka Yamamoto, Yuka Kaneko, Atsushi Noda, & Hiroyuki Naito. (2014). Effects of conventional anticonvulsant drugs on generalized tonic-clonic seizures in Noda epileptic rats. Epilepsy Research. 108(7). 1158–1167. 4 indexed citations
12.
Nagai, Junya, et al.. (2014). Fatty acid-bearing albumin but not fatty acid-depleted albumin induces HIF-1 activation in human renal proximal tubular epithelial cell line HK-2. Biochemical and Biophysical Research Communications. 450(1). 476–481. 9 indexed citations
13.
Abiko, Kaoru, Masaki Mandai, Junzo Hamanishi, et al.. (2013). PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction. Clinical Cancer Research. 19(6). 1363–1374. 187 indexed citations
14.
Nagai, Junya, Ayaka Yamamoto, Ryoko Yumoto, & Mikihisa Takano. (2013). Albumin overload induces expression of hypoxia-inducible factor 1α and its target genes in HK-2 human renal proximal tubular cell line. Biochemical and Biophysical Research Communications. 434(3). 670–675. 11 indexed citations
15.
Yamamoto, Ayaka, et al.. (2009). Alanine Scanning Analyses of the Three Major Loops in Domain II of Bacillus thuringiensis Mosquitocidal Toxin Cry4Aa. Applied and Environmental Microbiology. 76(3). 860–865. 17 indexed citations
16.
Ishida, Hisahito, Yukihiko Shirayama, Masaaki Iwata, et al.. (2007). Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant‐like effect via Y1 receptor. Hippocampus. 17(4). 271–280. 53 indexed citations
17.
Iwata, Masaaki, Katsumasa Muneoka, Yukihiko Shirayama, Ayaka Yamamoto, & R Kawahara. (2005). A study of a dendritic marker, microtubule-associated protein 2 (MAP-2), in rats neonatally treated neurosteroids, pregnenolone and dehydroepiandrosterone (DHEA). Neuroscience Letters. 386(3). 145–149. 25 indexed citations
18.
Sugie, Kazuma, Ayaka Yamamoto, Megumu Ogawa, et al.. (2003). Characterization of Danon disease in a male patient and his affected mother. Neuromuscular Disorders. 13(9). 708–711. 27 indexed citations
19.
Takahashi, Maki, Ayaka Yamamoto, Kyoko Takano, et al.. (2002). Germline mosaicism of a novel mutation in lysosome‐associated membrane protein‐2 deficiency (Danon disease). Annals of Neurology. 52(1). 122–125. 25 indexed citations
20.
Nishino, Ichizo, Jin Fu, Kurenai Tanji, et al.. (2000). Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature. 406(6798). 906–910. 702 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026